Still time to register: “Updates to Management of TB Meningitis”, this upcoming Mon 10/5 @ 2:30pm ET/11:30am PT Featuring clinical management of TB meningitis including standard vs. high-dose rifampin. Provided by NTCA, Curry TB Center & HeartlandTB Center www.currytbcenter.uc...
National TB Coalition of America (NTCA)
@tbcoalitionamerica.bsky.social
https://nationaltbcoalition.org
LETTER CLOSES TODAY! Urgent action is needed to ensure access to TB meds for children in the USA. In response, the NSTC Pediatric Formulary Work Group and TB Alliance are sponsoring a pediatric TB drug access congressional sign-on letter. Link:
Pediatric TB Drug Access Sign-On Letter
Please sign the below letter directed to House Energy and Commerce leaders and Senate Health, Education, Labor, and Pensions Committee leaders to immediately allow the United States to procure pediatric TB medications through the GDF and ultimately to develop a pathway for FDA approval of dispersible pediatric TB drugs so they may be readily available here in the United States. The letter is open to organizations and individual signers. The deadline to join the letter is end of day July 15. For any questions, please contact Donna Wegner at dhwegener.ntca@gmail.com. _________________________________________________ Dear Senators Cassidy and Sanders and Representatives Guthrie and Pallone: On behalf of the undersigned organizations and individuals, we urgently request your support to ensure access to appropriate tuberculosis (TB) medications for children in the United States. Currently, children are treated with pills designed for adults, which have to be crushed or suspended in liquids in an inconsistent manner. While child appropriate formulations of pediatric TB medications are available in more than 123 countries around the world, they are not available to children in the United States because of regulatory and cost barriers. While FDA approval of pediatric TB medications is the ultimate solution, this will take several years and still lacks appropriate funding. We need an immediate solution and urge you to allow the United States to access these medications through the Global Drug Facility (GDF)—a bundled drug procurement mechanism that supplies quality-assured TB treatments and diagnostics to 165 countries worldwide. TB—a highly contagious airborne bacterial infection—is the world’s deadliest infectious disease. Each year more than 10 million people fall ill with TB around the world, including approximately 1.25 million children 14 or younger. In 2024 an estimated 1.23 million people died of TB including an estimated 174,000 children and young adolescents (<15 years). While often fatal if untreated, TB is curable with antibiotics. Although the United States has one of the lowest TB rates in the world, TB outbreaks continue to occur. Between 2017 and 2023, the United States had 50 large TB outbreaks, and in 2025 there were over 10,200 cases of TB in the United States. Recently, a large TB outbreak in Kansas resulted in nearly 70 people developing active TB. Of those individuals, 17 were children aged 15 years or younger—representing 24 percent of all cases in the outbreak. Unfortunately, in large TB outbreak cases in the United States, children 15 years and younger are often disproportionately affected, representing 15 percent of cases compared to 3 percent in smaller outbreaks. This is in part due to ongoing challenges to provide adequate treatment for children in the United States with TB. While most of the world has access to approved, high-quality, effective water-dispersible, flavored pediatric TB drugs, children with TB in the United States are unfortunately treated with arcane methods—with estimated amounts of adult medications being crushed and blended into yogurt, apple sauce, or other foods that the child will swallow. Efforts are underway to bring pediatric dispersible TB medications to the U.S. market directly; however, there is a lack of current funding to formulate and manufacture these products for FDA approval. Once funding is secured, this process will take years, and we need these drugs for our patients now. We are working with the GDF to allow the United States to procure these drugs for patients here at home, however, TB controllers and United States physicians are not allowed to use this drug procurement mechanism despite years of United States government funding support for the GDF. We ask that Congress work with us to immediately allow the United States to procure pediatric TB medications through the GDF or other countries with similarly stringent regulatory authorities and ultimately to develop a pathway for FDA approval of dispersible pediatric TB drugs so they may be readily available here in the United States. Thank you for your consideration. For any questions on this issue, please reach out to Erin Morton with the TB Alliance, at emorton@dc-crd.com. Sincerely,
docs.google.com
Yesterday’s session, “Landscape of Generic TB Drugs in the United States & potential long term solutions” offered a look at the reality for TB programs’ drug procurement options and possible alternatives. Thanks to our presenters!
Thank you to all the presenters in today’s general session, “Taming the Chaos: Meeting and Beating Programmatic Challenges.” We learned so much from all of you.
We're happy to be here at the 30th National TB Conference with NTCA and CTCA in Palm Springs, CA this week. If you're here, please stop by our booth to connect with us! #TB #NTCACTCA2026 #GotCurry #Tuberculosis @tbcoalitionamerica.bsky.social
Thanks to Erin for sharing her experience with #tuberculosis and the impact of isolation at the 30th National TB Conference. We appreciate this opportunity for Erin to share & to help healthcare workers understand the difficulties that isolation places on people in TB treatment and to improve care!
At the 30th National TB Conference, a “coming attraction” was announced — the TB Nurse Case Manager Certificate Program! We cannot wait to formally support your professional development as you care for those with TB!
Our session on “Meeting and Beating Programmatic Challenges” is now happening at the 30th National TB Conference! Hear how TB programs across the USA responded to various obstacles and still delivered care to their communities.
We are underway at the 30th National TB Conference in Palm Springs, CA! Thank you to the planning committee for your hard work leading up to the conference, we are excited to begin a great week of sessions! #tuberculosis #EndTB #TBfreeUSA #TBfreeCalifornia
Tomorrow! Our next quarterly All Member call is tomorrow, Thursday, May 21st, at 3:00 pm ET/2:00 pm CT/1:00 pm MT/12:00 pm PT. Please join us & register in advance: us02web.zoom.us/webi...
CDC’s Division of Tuberculosis Elimination’s (DTBE) recently published an article in the Morbidity and Mortality Weekly Report (MMWR) entitled, “Large Outbreaks of Tuberculosis — United States, 2017–2023.” To read the full article: www.cdc.gov/mmwr/vol...
Plan your trip to the National TB Conference at the Omni Rancho Las Palmas in Palm Springs, CA! A block of rooms is available at the Federal per diem rate of $ 141 + taxes & no fees! To make your hotel reservations, click here or visit our new website: tinyurl.com/Book-Roo...
NTCA Board & staff are excited & proud to share the new NTCA website. Please take a look at the new website at the link below and remember to bookmark it for future reference! nationaltbcoalition.org
The 2026 UCSF-SFDPH World TB Day Symposium is happening today! Highlights include: 🔹Keynote presentation by Dr. Paula Fujiwara: Yes, We Can (Still) End TB—Led by Science, Powered by Communities for Action #WorldTBDay #Tuberculosis #EndTB @ucsf-ctb.bsky.social #UCSFWorldTBDay #WorldTBDay2026
It’s World TB Day and we are so grateful for the support We Are TB and Somos TB has received over the years from our partners in the fight against tuberculosis. We affirm our dedication and solidarity with people fighting this disease everywhere. Yes we can! #EndTB
NTCA is committed to our shared mission of ending TB! NTCA President Jason Cummins shares his thoughts on this 2026 World TB Day. Click here to access: conta.cc/476zZYl
The 30th NTC includes opportunities for abstract poster presentations, and for those highly scored submissions, the invitation to deliver an oral abstract presentation during the plenary sessions! Abstracts are due on Friday, April 10, 2026. Submit here: www.cvent.com/c/abst...
NTCA President & TN TB Program Director Jason Cummins shared info on US TB programs with legislators this week on #TBHillDay. Thank you to the offices of Sen. Hagerty, Rep. DeLauro, Rep. Rose, Rep. Fleischmann, Rep. Scott & Rep. Letlow for meeting w Jason and the TB Roundtable!
Diane represented the great state of Ohio & #tuberculosis survivors everywhere in her meetings on TB Hill Day! Thank you to the offices of Rep. Guy Reschenthaler, Sen. John Husted, @berniemoreno.bsky.social and Rep. Joyce Beatty for meeting with Diane & the TB Roundtable! #SwagLikeOhio #TBhillDay
Let’s hear it for HESBORN! 🙌👏 Hesborn shared his experience with tuberculosis with legislators this week on #TBHillDay. Thank you to the offices of @cantwell.senate.gov Rep Jim Himes @delauro.house.gov @repdelbene.bsky.social @murray.senate.gov for meeting with Hesborn & the TB Roundtable.
Thank you to the orgs that generously provided financial support to the travel/expenses of We Are TB & Somos TB at the 2026 #TBHillDay. The inclusion of lived experience at all events for tuberculosis is essential, & we couldn’t be there without your support. We are very grateful! #EndTB #TBfreeUSA
Do NOT mess with Texas or #WeAreTB’s Tiffany, who shared her #tuberculosis knowledge & experience this week on #TBHillDay! Thank you to the offices of Rep. Alford, Sen. Cruz and Rep. Juan Cuscomani of AZ for speaking with Tiffany! #EndTB #TBfreeUSA @tbfighters.org
NTCA was proud to be a part of 2026’s ‘TB Hill Day’. We love sharing our passion for TB elimination w/ lawmakers & hope for more support for TB programs & research! This was the largest TB Hill Day ever - over 250 meetings! More to come & happy to help our members get involved.
The call for nominations for NTCA 2026-27 leadership is open through 2/26/26. Email Donna W. or check out our website! NTCA is accepting nominations for open positions on our board. In addition, each of the 3 sections within NTCA (NTNC, NSTC & SETC) have open positions! Thanks!
Want to know what's new and exciting in the #Tuberculosis world? Our friends at IAVI, @tballiance.bsky.social, and @treatmentactiongroup.org are on deck to teach us about TB Innovations & Breakthroughs! Join us for a livestream this Thursday at 8pm ET/5pm PT. https://www.youtube.com/live/H058Uk-H5N0
Webinar Recording Now Available! More Than Meets the Eye: Understanding Ocular Tuberculosis www.currytbcenter.ucsf.edu/trainings/ar... #Tuberculosis #CurryTBCenter #GotCurry #OcularTB @tbcoalitionamerica.bsky.social
Bumping this up again because this one really means a lot to me. I’m lucky enough to get to work with these amazing people on #tbhillday and a little bonus adventure for #p4a
2026 Project For Awesome: We Are TB
YouTube video by Tori Sandifer
youtu.be
After years and years of lurking, I made my first ever @projectforawesome.com video. @wearetb.bsky.social is an amazing group of people doing really good work. They're actively decreasing world suck. More than happy to answer any follow up questions! #p4a2026
On behalf of the NTCA Board, Section leadership, and staff, may this Valentine's Day be very special and full of love! - Jason Cummins, NTCA President Read our e-newsletter here: conta.cc/3ZvNDA8 #tuberculosis #TBfreeUSA